Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 10/20 | 0.47 |
| ▸ | SMPD1 | P17405 | 4/20 | 0.47 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31149403 | 1.00 | FDPS (0.47) | FDPSSMPD1GGPS1 | |
| Hydrochloric Acid SCHEMBL28559435 | 0.84 | FDPS (0.45) | FDPSSMPD1GGPS1 | |
| Hydrochloric Acid SCHEMBL28969844 | 0.84 | FDPS (0.45) | FDPSSMPD1GGPS1 | |
| Hydrochloric Acid SCHEMBL28980692 | 0.82 | FDPS (0.44) | FDPSSMPD1GGPS1 | |
| SCHEMBL19201137 | 0.80 | FDPS (0.46) | FDPSSMPD1GGPS1 | |
| SCHEMBL6938402 | 0.80 | FDPS (0.50) | FDPSSMPD1GGPS1 | |
| SCHEMBL4141311 | 0.80 | FDPS (0.50) | FDPSSMPD1GGPS1 | |
| SCHEMBL22799931 | 0.80 | FDPS (0.46) | FDPSSMPD1GGPS1 | |
| SCHEMBL4286298 | 0.80 | FDPS (0.50) | FDPSSMPD1GGPS1 | |
| SCHEMBL9205361 | 0.80 | FDPS (0.50) | FDPSSMPD1GGPS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108472246-A | Colloidal solid for being used in drug | 剑桥生物制药专利有限公司 | 2018-08-31 | — | — | CN | claimed |
| EP-1603535-A4 | AROMATASE INHIBITOR DIAGNOSIS AND THERAPY | ETHICON INC (US) | 2008-10-15 | — | — | EP | disclosed |
| EP-1616182-A4 | ENZYME REPLACEMENT THERAPY WITH 17-BETA-HYDROXYSTEROID DEHYDROGENASE-TYPE 2 | ETHICON INC (US) | 2008-04-16 | — | — | EP | disclosed |
| EP-1616182-A2 | ENZYME REPLACEMENT THERAPY WITH 17-BETA-HYDROXYSTEROID DEHYDROGENASE-TYPE 2 | ETHICON, INC. (US) | 2006-01-18 | — | — | EP | disclosed |
| EP-1603535-A2 | AROMATASE INHIBITOR DIAGNOSIS AND THERAPY | ETHICON, INC. (US) | 2005-12-14 | — | — | EP | disclosed |
| WO-2004082627-A2 | ENZYME REPLACEMENT THERAPY WITH 17-β-HYDROXYSTEROID DEHYDROGENASE-TYPE 2 | ETHICON, INC. (US) | 2004-09-30 | — | — | WO | disclosed |
| WO-2004082626-A2 | AROMATASE INHIBITOR DIAGNOSIS AND THERAPY | ETHICON, INC. (US) | 2004-09-30 | — | — | WO | disclosed |